Skip to main content

Advertisement

SpringerLink
Log in

Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Chronic kidney disease (CKD) is associated with altered calcium-phosphate homeostasis and hyperparathyroidism due to decreased activity of 1α-hydroxylase and impaired activation of 25-hydroxyvitamin D3 [25(OH)D3]. In some patients these problems start earlier because of vitamin D deficiency. A retrospective review of patients followed in the chronic renal insufficiency clinic at Children’s Hospital of Michigan assessed the prevalence of vitamin D deficiency in CKD stages 2–4 and evaluated the effect of treatment with ergocalciferol on serum parathormone (PTH). Blood levels of 1,25 dihydroxyvitamin D3, 25(OH)D3, and parathormone (PTH) were examined in 57 children (40 boys; mean age 10.6 years). Of 57 subjects, 44 (77.2%) had 25(OH)D3 levels ≤30 ng/ml, with overall mean of 26.4 ± 14.3 ng/ml. PTH for patients with 25(OH)D3 levels >30 ng/ml was 67.84 ± 29.09 ng/ml and in the remaining patients was elevated, at 120.36 ± 86.42 ng/ml (p = 0.05). Following ergocalciferol treatment (22), PTH decreased from 122.13 ± 82.94 ng/ml to 80.14 ± 59.24 ng/ml (p < 0.001) over a period of 3 months. We conclude that vitamin D deficiency is common in children with CKD stages 2–4 and is associated with hyperparathyroidism in the presence of normal 1,25 dihydroxyvitamin D3. Its occurrence before significant renal impairment is noteworthy. Early diagnosis and appropriate treatment is emphasized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. United States Renal Data System (USRDS) (2007) Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD

  2. Chadha V, Warady BA (2005) Epidemiology of pediatric chronic kidney disease. Adv Chronic Kidney Dis 12:343–352

    Article  Google Scholar 

  3. National Kidney Foundation (2005) K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46:S1–S121

    Google Scholar 

  4. Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ (2004) Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24:503–510

    Article  CAS  Google Scholar 

  5. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS, National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (2003) Clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421

    Article  Google Scholar 

  6. Cozzolino M, Gallieni M, Brancaccio D, Arcidiacono T, Bianchi G, Vezzoli G (2006) Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. J Nephrol 19:566–577

    CAS  PubMed  Google Scholar 

  7. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ (2004) Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158:531–537

    Article  Google Scholar 

  8. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439–443

    Article  CAS  Google Scholar 

  9. McKenna MJ, Freaney R (1998) Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 8(Suppl 2):S3–S6

    Article  Google Scholar 

  10. Zadshir A, Tareen N, Pan D, Norris K, Marins D (2005) The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 15:S5–97-101

    PubMed  Google Scholar 

  11. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338:777–783

    Article  CAS  Google Scholar 

  12. Tangpricha V, Pearce EN, Chen TC, Holick MF (2002) Vitamin D insufficiency among free-living healthy young adults. Am J Med 112:659–662

    Article  CAS  Google Scholar 

  13. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45:1026–1033

    Article  CAS  Google Scholar 

  14. Birge SJ, Haddad JG (1975) 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 56:1100–1107

    Article  CAS  Google Scholar 

  15. Klaus G, Watson A, Edefonti A, Fischbach M, Ronnholm K, Schaefer F, Simkova E, Stefanidis CJ, Strazdins V, Vande Walle J, Schroder C, Zurowska A, Ekim M, European Pediatric Dialysis Working Group (EPDWG) (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21:151–159

    Article  CAS  Google Scholar 

  16. Lafage MH, Combe C, Fournier A, Aparicio M (1992) Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy. Kidney Int 42:1217–1225

    Article  CAS  Google Scholar 

  17. Khan S (2007) Vitamin D deficiency and secondary hyperparathyroidism among patients with chronic kidney disease. Am J Med Sci 333:201–207

    Article  Google Scholar 

  18. Holick MF (1987) Vitamin D and the kidney. Kidney Int 32:912–929

    Article  CAS  Google Scholar 

  19. Coburn JW, Koppel MH, Brickman AS, Massry SG (1973) Study of intestinal absorption of calcium in patients with renal failure. Kidney Int 3:264–272

    Article  CAS  Google Scholar 

  20. Saha H (1994) Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol 41:290–296

    CAS  PubMed  Google Scholar 

  21. Langman CB, Brooks ER (2006) Renal osteodystrophy in children: a systemic disease associated with cardiovascular manifestations. Growth Horm IGF Res 16(Suppl A):S79–S83

    Article  Google Scholar 

  22. Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H (1999) Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55:1019–1027

    Article  CAS  Google Scholar 

  23. Halloran BP, Schaefer P, Lifschitz M, Levens M, Goldsmith RS (1984) Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab 59:1063–1069

    Article  CAS  Google Scholar 

  24. Fournier A, Bordier P, Gueris J, Sebert JL, Marie P, Ferrière C, Bedrossian J, DeLuca HF (1979) Comparison of 1 alpha (OH)2 vitamin D3 and 25 OH vitamin D3 in the treatment of renal osteodystrophy: greater effect of 25 OH vitamin D3 on bone mineralization. Kidney Int 15:196–204

    Article  CAS  Google Scholar 

  25. Stefanidis CJ, Klaus G (2007) Growth of prepubertal children on dialysis. Pediatr Nephrol 22:1251–1259

    Article  Google Scholar 

  26. Fournier A, Harbouche L, Mansour J, Shahapuni I (2007) Impact of calcium and vitamin D therapy on arterial and cardiac disease in young adults with childhood-onset end stage renal disease. Nephrol Dial Transplant 22:956–957

    Article  Google Scholar 

  27. Al-Aly Z, Qazi RA, González EA, Zeringue A, Martin KJ (2007) Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 50:59–68

    Article  CAS  Google Scholar 

  28. Zisman AL, Hristova M, Ho LT, Sprague SM (2007) Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 27:36–43

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Nephrology and Hypertension, Children’s Hospital of Michigan, 3901 Beaubien Blvd, Detroit, MI, 48201, USA

    Shina Menon, Rudolph P. Valentini, Guillermo Hidalgo, Lena Peschansky & Tej K. Mattoo

Authors
  1. Shina Menon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rudolph P. Valentini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guillermo Hidalgo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lena Peschansky
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tej K. Mattoo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shina Menon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Menon, S., Valentini, R.P., Hidalgo, G. et al. Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 23, 1831–1836 (2008). https://doi.org/10.1007/s00467-008-0842-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-008-0842-x

Keywords

Search

Navigation